Fundraising Fox
Draupnir Bio
Copenhagen, DK · Founded 2017 · 19 employees on LinkedIn · 4 known investors
Find your way into Draupnir Bio
Sign up to see every warm intro you have to Draupnir Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Draupnir Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Draupnir Bio develops targeted protein degradation therapies using sortilin-based lysosome targeting chimeras to clear extracellular and membrane-bound protein aggregates in proteinopathies. The company, a spin-out from Aarhus University and Max-Planck Society, builds proprietary platform technology to treat diseases with significant unmet medical need.
Founders & leadership
Draupnir Bio was founded in 2017 by Simon Glerup, Camilla Gustafsen, Peder Søndergaard Madsen, and Peter Seeberger.
Investors · 4
How we know: the company's own site · Inkef's portfolio page · a partner's Signal profile · press coverage · the VCSheet dataset · Not right? Tell us
How we know: the company's own site · press coverage · Not right? Tell us
How we know: MC Healthcare Ventures's portfolio page · Not right? Tell us
How we know: press coverage · Not right? Tell us
In the news
Frequently asked questions
- What does Draupnir Bio do?
- Draupnir Bio develops targeted protein degradation therapies using sortilin-based lysosome targeting chimeras to clear extracellular and membrane-bound protein aggregates in proteinopathies. The company, a spin-out from Aarhus University and Max-Planck Society, builds proprietary platform technology to treat diseases with significant unmet medical need.
- Who founded Draupnir Bio?
- Draupnir Bio was founded by Simon Glerup, Camilla Gustafsen, Peder Søndergaard Madsen, Peter Seeberger in 2017.
- Who are Draupnir Bio's investors?
- Draupnir Bio's investors include Inkef, Gilde Healthcare, MC Healthcare Ventures, Novo Holdings.
- Where is Draupnir Bio headquartered?
- Draupnir Bio is headquartered in Copenhagen, DK.